RA Capital Management - DICE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$365,018,194
+62.2%
7,856,6120.0%6.89%
+35.2%
Q1 2023$225,091,934
+5.3%
7,856,612
+14.7%
5.10%
+17.6%
Q4 2022$213,686,023
+102.3%
6,848,911
+31.5%
4.33%
+92.3%
Q3 2022$105,637,000
+30.7%
5,208,9110.0%2.25%
+4.6%
Q2 2022$80,842,000
-18.9%
5,208,9110.0%2.16%
-0.9%
Q1 2022$99,646,000
-24.4%
5,208,9110.0%2.17%
-6.5%
Q4 2021$131,838,000
-22.7%
5,208,9110.0%2.32%
-1.7%
Q3 2021$170,592,0005,208,9112.36%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$102,737,57555.73%
Sands Capital Ventures, LLC 2,748,970$85,76823.49%
OUP Management Co., LLC 268,346$8,372,39513.67%
New Leaf Venture Partners, L.L.C. 371,693$11,596,8228.40%
RA Capital Management 6,848,911$213,686,0234.33%
VR Adviser, LLC 819,000$25,552,8004.30%
SVB FINANCIAL GROUP 42,358$1,321,5703.61%
Logos Global Management LP 660,000$20,592,0002.41%
Deep Track Capital, LP 1,734,143$54,105,2622.27%
Samsara BioCapital, LLC 202,773$6,326,5181.36%
View complete list of DICE THERAPEUTICS INC shareholders